1. Home
  2. OBIO
  3. OBIO News

Latest Orchestra BioMed Holdings Inc. (OBIO) News on July 13, 2025

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025
OBIO

GlobeNewswire

25 days ago

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025

OBIO

MT Newswires

a month ago

B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating

Sidoti Events, LLC's Virtual May Micro-Cap Conference
OBIO

ACCESS Newswire

2 months ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
OBIO

Zacks

2 months ago

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
OBIO

GlobeNewswire

2 months ago

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure
OBIO

GlobeNewswire

2 months ago

Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates
OBIO

Zacks

2 months ago

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
OBIO

Zacks

2 months ago

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

OBIO

MT Newswires

2 months ago

Orchestra BioMed Receives US FDA Approval for Heart Device Trial

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon
OBIO

GlobeNewswire

2 months ago

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
OBIO

GlobeNewswire

2 months ago

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
OBIO

GlobeNewswire

3 months ago

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

OBIO

MT Newswires

3 months ago

Orchestra BioMed Says AVIM Therapy Gets US FDA Breakthrough Device Designation

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
OBIO

GlobeNewswire

3 months ago

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates
OBIO

Zacks

3 months ago

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
OBIO

GlobeNewswire

3 months ago

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

Freightos And 2 Other Penny Stocks Worth Watching
OBIO

Simply Wall St.

4 months ago

Freightos And 2 Other Penny Stocks Worth Watching

OBIO

MT Newswires

4 months ago

BTIG Initiates Orchestra BioMed at Buy With $12 Price Target

Orchestra BioMed to Present at Upcoming Investor Conferences
OBIO

GlobeNewswire

5 months ago

Orchestra BioMed to Present at Upcoming Investor Conferences

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board
OBIO

GlobeNewswire

5 months ago

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

OBIO

MT Newswires

5 months ago

Orchestra BioMed Says AVIM Therapy Improves Echo Markers of Diastolic Dysfunction

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference
OBIO

GlobeNewswire

5 months ago

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
OBIO

GlobeNewswire

5 months ago

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

US Penny Stocks Spotlight: AC Immune And Two Others To Consider
OBIO

Simply Wall St.

6 months ago

US Penny Stocks Spotlight: AC Immune And Two Others To Consider

Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds
OBIO

Simply Wall St.

7 months ago

Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting
OBIO

GlobeNewswire

7 months ago

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
OBIO

GlobeNewswire

8 months ago

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations
OBIO

Simply Wall St.

8 months ago

Orchestra BioMed Holdings Third Quarter 2024 Earnings: Beats Expectations

We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully
OBIO

Simply Wall St.

8 months ago

We Think Orchestra BioMed Holdings (NASDAQ:OBIO) Needs To Drive Business Growth Carefully

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates
OBIO

Zacks

8 months ago

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Tops Revenue Estimates

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
OBIO

GlobeNewswire

8 months ago

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

Orchestra BioMed to Participate in Jefferies London Healthcare Conference
OBIO

GlobeNewswire

8 months ago

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

Travere (TVTX) Surges 11.6%: Is This an Indication of Further Gains?
OBIO

Zacks

9 months ago

Travere (TVTX) Surges 11.6%: Is This an Indication of Further Gains?

OBIO

Argus Research

10 months ago

Daily – Vickers Top Buyers & Sellers for 09/27/2024

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Lags Revenue Estimates
OBIO

Zacks

a year ago

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Lags Revenue Estimates

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

Orchestra BioMed Holdings, Inc. (OBIO) Loses -25.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
OBIO

Zacks

a year ago

Orchestra BioMed Holdings, Inc. (OBIO) Loses -25.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Earnings Preview: Fortrea Holdings Inc. (FTRE) Q2 Earnings Expected to Decline
OBIO

Zacks

a year ago

Earnings Preview: Fortrea Holdings Inc. (FTRE) Q2 Earnings Expected to Decline

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Should You Buy?
OBIO

Zacks

a year ago

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Should You Buy?

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors

Orchestra BioMed Holdings, Inc. (OBIO) Upgraded to Buy: Here's What You Should Know
OBIO

Zacks

a year ago

Orchestra BioMed Holdings, Inc. (OBIO) Upgraded to Buy: Here's What You Should Know

Wall Street Analysts Believe Orchestra BioMed Holdings, Inc. (OBIO) Could Rally 102.61%: Here's is How to Trade
OBIO

Zacks

a year ago

Wall Street Analysts Believe Orchestra BioMed Holdings, Inc. (OBIO) Could Rally 102.61%: Here's is How to Trade

Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
OBIO

GlobeNewswire

a year ago

Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances

Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?
OBIO

Zacks

a year ago

Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?

Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are individual investors with 37% ownership, public companies own 16%
OBIO

Simply Wall St.

a year ago

Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are individual investors with 37% ownership, public companies own 16%

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
OBIO

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
OBIO

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
OBIO

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge
OBIO

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally
OBIO

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
OBIO

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
OBIO

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
OBIO

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Lotto 6/49 - $64 million up for grabs in the next draw!
OBIO

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
OBIO

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
OBIO

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
OBIO

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
OBIO

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
OBIO

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
OBIO

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
OBIO

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

All You Need to Know About Orchestra BioMed Holdings, Inc. (OBIO) Rating Upgrade to Buy
OBIO

Zacks

a year ago

All You Need to Know About Orchestra BioMed Holdings, Inc. (OBIO) Rating Upgrade to Buy

Does Orchestra BioMed Holdings, Inc. (OBIO) Have the Potential to Rally 135.64% as Wall Street Analysts Expect?
OBIO

Zacks

a year ago

Does Orchestra BioMed Holdings, Inc. (OBIO) Have the Potential to Rally 135.64% as Wall Street Analysts Expect?

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
OBIO

GlobeNewswire

a year ago

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates
OBIO

Zacks

a year ago

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
OBIO

GlobeNewswire

a year ago

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

Orchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
OBIO

Simply Wall St.

a year ago

Orchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting

Orchestra BioMed to Participate in Upcoming Investor Conferences
OBIO

GlobeNewswire

a year ago

Orchestra BioMed to Participate in Upcoming Investor Conferences

Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients

Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years
OBIO

GlobeNewswire

a year ago

Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years

Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season
OBIO

Zacks

a year ago

Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season

Why You Might Be Interested In Oppenheimer Holdings Inc. (NYSE:OPY) For Its Upcoming Dividend
OBIO

Simply Wall St.

a year ago

Why You Might Be Interested In Oppenheimer Holdings Inc. (NYSE:OPY) For Its Upcoming Dividend

Should Value Investors Buy Dave & Buster's Entertainment (PLAY) Stock?
OBIO

Zacks

a year ago

Should Value Investors Buy Dave & Buster's Entertainment (PLAY) Stock?

One Funko Insider Raised Their Stake In The Previous Year
OBIO

Simply Wall St.

a year ago

One Funko Insider Raised Their Stake In The Previous Year

Greenfire Resources Announces Operational Update, Including Strong Initial Refill Well Results and New WTI Hedging Program
OBIO

Newsfile

a year ago

Greenfire Resources Announces Operational Update, Including Strong Initial Refill Well Results and New WTI Hedging Program

Excelerate Energy Signs 15-Year LNG Supply Deal with QatarEnergy
OBIO

Business Wire

a year ago

Excelerate Energy Signs 15-Year LNG Supply Deal with QatarEnergy

ACNB (ACNB) is a Top Dividend Stock Right Now: Should You Buy?
OBIO

Zacks

a year ago

ACNB (ACNB) is a Top Dividend Stock Right Now: Should You Buy?

Investors in Donegal Group (NASDAQ:DGIC.A) have seen decent returns of 39% over the past five years
OBIO

Simply Wall St.

a year ago

Investors in Donegal Group (NASDAQ:DGIC.A) have seen decent returns of 39% over the past five years

Washington Trust Bancorp (WASH) Surpasses Q4 Earnings Estimates
OBIO

Zacks

a year ago

Washington Trust Bancorp (WASH) Surpasses Q4 Earnings Estimates

OBIO

Associated Press Finance

a year ago

Washington Trust: Q4 Earnings Snapshot

Washington Trust Reports Fourth Quarter and Full-Year 2023 Earnings
OBIO

PR Newswire

a year ago

Washington Trust Reports Fourth Quarter and Full-Year 2023 Earnings

Bar Harbor Bankshares (BHB) Q4 Earnings and Revenues Beat Estimates
OBIO

Zacks

a year ago

Bar Harbor Bankshares (BHB) Q4 Earnings and Revenues Beat Estimates

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
OBIO

GlobeNewswire

a year ago

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

Star Group LP's Dividend Analysis
OBIO

GuruFocus.com

a year ago

Star Group LP's Dividend Analysis

Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy
OBIO

PR Newswire

a year ago

Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy

Why Is DoubleVerify (DV) Stock Soaring Today
OBIO

StockStory

a year ago

Why Is DoubleVerify (DV) Stock Soaring Today

Calculating The Fair Value Of Vishay Precision Group, Inc. (NYSE:VPG)
OBIO

Simply Wall St.

a year ago

Calculating The Fair Value Of Vishay Precision Group, Inc. (NYSE:VPG)

Nkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains
OBIO

Simply Wall St.

a year ago

Nkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains

Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice
OBIO

Zacks

a year ago

Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice

Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently
OBIO

Insider Monkey

a year ago

Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently

Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested five years ago
OBIO

Simply Wall St.

a year ago

Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested five years ago

Shareholders Would Not Be Objecting To Franklin Covey Co.'s (NYSE:FC) CEO Compensation And Here's Why
OBIO

Simply Wall St.

a year ago

Shareholders Would Not Be Objecting To Franklin Covey Co.'s (NYSE:FC) CEO Compensation And Here's Why

Insider Sell: COO Michael Bruen Sells 5,000 Shares of Bowman Consulting Group Ltd
OBIO

GuruFocus.com

a year ago

Insider Sell: COO Michael Bruen Sells 5,000 Shares of Bowman Consulting Group Ltd

Why Aehr Test Systems Stock Plunged Today
OBIO

Motley Fool

2 years ago

Why Aehr Test Systems Stock Plunged Today

Share on Social Networks: